• Skip to primary navigation
  • Skip to main content

EACVA

European Association of Certified Valuators and Analysts

  • Home
  • Association
    • EACVA’s Mission
    • Benefits of Membership
    • Classifications of Membership
    • Become a Member
    • NACVA / EACVA Professional Standards
    • NACVA | GACVA Standard Comparison Charts
  • Certified Valuation Analyst (CVA)
    • CVA Training and Exam
    • CVA Training and Exam Registration
    • Info Webcast: Certified Valuation Analyst (CVA)
    • The Core Body of Knowledge for Business Valuations
    • ANSI & NCCA Accredited
    • CVA Candidate Status
  • Business Valuation Events
    • Webcast – Around the Valuation World international
    • Annual International Business Valuation Conference 2023
    • Business Valuation Seminars
      • Live Web-Seminar: Valuation Meets ESG & Sustainability
    • Introduction to Business Valuation – Free Webcasts
  • European Business Valuation Magazine (EBVM)
    • Become an Author
  • Blog
  • Contact Us
  • Show Search
Hide Search

KPMG’s Quarterly Brief –International Valuation Newsletter 2020-Q4

Wolfgang Kniest · November 16, 2020

Photo by Annie Spratt on Unsplash.

The Quarterly Brief –International Valuation Newsletter discusses current topics of busisness valuation.

Focus of the latest edition is on insights into the value drivers of pharmaceutical and biotechnology companies, with a particular focus on vaccine developers.

The following issues are emphasized: Sub sectors, economic factors, valuation approaches, uncertainty/COVID-19, and in addition key capital market data, i.e. for Austria and for BRICS countries.

Follow the Link.

Organization

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Join EACVA today. Apply for Membership.

Learn More

Copyright © 2023 EACVA. All rights reserved.

  • Contact Us
  • Privacy Policy
  • Imprint